-
Sanofi to invest €350m in new Canadian vaccine plant
pharmafile
April 13, 2018
Sanofi has announced plans to spend €350 million on a new vaccine facility located in Toronto, Canada, a move which, according to the company, is one of its biggest-ever investments in a single building.
-
BiondVax Begins NIH-Sponsored Phase 2 Clinical Trial of Its Universal Flu Vaccine in the United States
biospace
April 12, 2018
The trial is sponsored by the US National Institute of Allergy and Infectious Disease.
-
H7N9 influenza vaccine clinical trials begin
europeanpharmaceuticalreview
March 20, 2018
Two new clinical trials testing an experimental vaccine to prevent influenza caused by an H7N9 influenza virus are now enrolling volunteers at sites across the United States…
-
TapImmune Announces Publication of Clinical Trial Results for the TPIV200 Cancer Vaccine in Clinical
biospace
March 16, 2018
TapImmune Inc.? today announced the publication of clinical data
-
World’s first synthetic, non-biologic vaccine developed
pharmafile
March 15, 2018
One of the major challenges in delivering vaccinations to all parts of the globe is the need to keep the temperature regulated, with vaccines needing to stay at a cool temperature no matter the climate of the region in which they are transported.
-
Antigen study provides a new approach to vaccine development for RSV
europeanpharmaceuticalreview
March 14, 2018
Medical researchers point to a promising route for designing an effective vaccine for the respiratory syncytial virus…
-
Sanofi Pasteur posts 8.3% growth despite 2017 vaccine setbacks
fiercepharma
February 12, 2018
Despite lots of challenges that cropped up during 2017, Sanofi's vaccines outfit grew revenues 8.3% in the year to €5.1 billion ($6.25 billion), helping the drug giant as its pharma segment struggled.
-
Takeda’s Zika Vaccine Candidate Receives U.S. FDA Fast Track Designation
americanpharmaceuticalreview
January 30, 2018
Takeda Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to TAK-426, Takeda’s purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate.
-
Mother’s antibodies may worsen dengue infection in children
biospectrumasia
January 29, 2018
A dengue vaccine that stimulates a strong T cell response in babies has been found to provide better and broader protection than vaccines which induce the production of mainly antibodies.
-
New vaccine provides universal protection against influenza A, study finds
pharmafile
January 25, 2018
Research led by Georgia State University has enabled the development of a universal vaccine for influenza A viruses, proven to provide long-lasting immunity in mice.
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
